InvestorsObserver
×
News Home

Should Medical Devices Stock Bluejay Diagnostics Inc (BJDX) Be in Your Portfolio Friday?

Friday, December 29, 2023 10:21 AM | InvestorsObserver Analysts

Mentioned in this article

Should Medical Devices Stock Bluejay Diagnostics Inc (BJDX) Be in Your Portfolio Friday?

Bluejay Diagnostics Inc (BJDX) is near the bottom in its industry group according to InvestorsObserver. BJDX gets an overall rating of 0. That means it scores higher than 0 percent of stocks. Bluejay Diagnostics Inc gets a 0 rank in the Medical Devices industry. Medical Devices is number 80 out of 148 industries.

Overall Score - 0
BJDX has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on BJDX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Bluejay Diagnostics Inc Stock Today?

Bluejay Diagnostics Inc (BJDX) stock is trading at $1.21 as of 10:19 AM on Friday, Dec 29, an increase of $0.03, or 2.13% from the previous closing price of $1.19. The stock has traded between $1.20 and $1.27 so far today. Volume today is 52,543 compared to average volume of 51,076. Click Here to get the full Stock Report for Bluejay Diagnostics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App